HSV-1's contribution as a vector for gene therapy
Nat Biotechnol
.
2022 Sep;40(9):1316.
doi: 10.1038/s41587-022-01449-1.
Author
Alberto L Epstein
1
Affiliation
1
EG427 Pinpoint Gene Therapy, Paris, France. alberto@eg427.com.
PMID:
36085499
DOI:
10.1038/s41587-022-01449-1
No abstract available
Publication types
Letter
Comment
MeSH terms
Genetic Therapy
Herpesvirus 1, Human* / genetics